Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarclo Regulatory News (CAR)

Share Price Information for Carclo (CAR)

Share Price is delayed by 15 minutes
Get Live Data
34.30    0.30 (0.88%)
Bid:
32.60
Ask:
34.00
Spread: 1.40 (4.294%)
Market Cap: £25.18m
CAR Live PriceLast checked at - London Stock Exchange

Intraday Carclo Share Chart

Trading Update

31 Jan 2017 07:00

RNS Number : 5163V
Carclo plc
31 January 2017
 

 

31 January 2017

Carclo plc

 ("Carclo" or the "Group")

Trading Update

 

The Board is pleased to announce that trading in the second half of the Group's current financial year remains strong and the outlook for the full year remains in line with its expectations.

Our Technical Plastics division is set to report a stronger second half performance, as expected, assisted by the contribution from Precision Tool & Die ("PTD"), acquired in October 2016. Our US business is trading well and the integration is progressing to plan. The expansion of our Bangalore facility in India is now underway and, once completed this summer, should double the capacity of our Indian business. Our Chinese operation, based in Taicang, continues to support the growth of its main medical customer while securing other new business opportunities.

In our LED Technologies division, Wipac supercar lighting product sales have been in line with our forecasts and this business continues to benefit from the significant design, development and tooling activities generated by the recent run of programme wins. Wipac continues to win new lighting programmes within the low volume sector and remains focussed on securing a further mid volume programme in the new financial year, which will support the anticipated strong growth of this business.

Our smaller LED Optics business has continued to benefit from strong demand and the project to move a part of the manufacturing business to our Technical Plastics facility in Brno, Czech Republic is running to plan. 

Our Aerospace business has continued to enjoy stable trading conditions in both its UK and French operations.

The Group's balance sheet remains strong, benefiting from the additional £3 million of funds raised in last October's equity placing to fund the acquisition of PTD. The Board anticipates that Group debt at the financial year end will be broadly in line with its expectations. The IAS19 pensions deficit, which had increased significantly due to the steep decline in corporate bond yields following the EU Referendum result in June 2016, is expected to have reduced modestly, reflecting the recent increase in the corporate bond yield used to discount the pension liability.

The Board remains positive about the Group's trading performance in the current financial year and its longer term prospects for further growth and increased profitability.

Later today, Carclo will be holding an investor event at its Wipac facility in Buckingham. The event is intended to provide a greater understanding of the Group's supercar lighting business. No new material trading information will be provided and the presentation materials will be available on the Investors section of Carclo's website following the event.

- ENDS -

 

 

 

Enquiries:

 

Carclo plc

 

01924 268040

Chris Malley, Chief Executive

 

 

Robert Brooksbank, Finance Director

 

 

 

 

 

Peel Hunt LLP

 

0207 418 8900

Justin Jones

 

 

Jock Maxwell Macdonald

 

 

Mike Bell

 

 

 

Weber Shandwick

Nick Oborne

Tom Jenkins

 

020 7067 0000

About Carclo

Carclo plc is a public company whose shares are quoted on the Main Market of the London Stock Exchange.

Carclo's strategy is to develop and expand its key manufacturing assets in markets where there are significant further opportunities to drive shareholder value. To enhance profit margins and support its customers, the group has been investing across its global footprint.

Approximately three fifths of group revenues are generated from the supply of fine tolerance, injection moulded plastic components, mainly for medical products. The balance of group revenue is derived mainly from the design and supply of specialised injection moulded LED based lighting systems to the premium automotive industry.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFVDLRIIVID
Date   Source Headline
6th Dec 20226:29 pmRNSHolding(s) in Company - Replacement
5th Dec 20224:40 pmRNSSecond Price Monitoring Extn
5th Dec 20224:35 pmRNSPrice Monitoring Extension
30th Nov 20227:00 amRNSHalf-year Report
15th Nov 20227:05 amRNSNotice of Interim Results & Investor Presentation
15th Nov 20227:00 amRNSDirectorate Change
7th Nov 20227:00 amRNSBoard Changes
18th Oct 20227:00 amRNSTrading Update
13th Oct 20221:22 pmRNSHolding(s) in Company
6th Oct 20221:05 pmRNSAppointment of Chief Executive Officer
16th Sep 20223:16 pmRNSHolding(s) in Company
5th Sep 20227:00 amRNSTripartite Financing Agreement Secured
2nd Sep 202212:51 pmRNSHolding(s) in Company - Correction
2nd Sep 202210:37 amRNSHolding(s) in Company
1st Sep 20223:48 pmRNSHolding(s) in Company
1st Sep 20223:20 pmRNSResults of Annual General Meeting
15th Aug 20227:00 amRNSChange of Financial Adviser and Corporate Broker
4th Aug 20227:00 amRNSDirector/PDMR Shareholding
25th Jul 202211:10 amRNS2022 Annual Report and Notice of AGM
18th Jul 20224:41 pmRNSSecond Price Monitoring Extn
18th Jul 20224:35 pmRNSPrice Monitoring Extension
12th Jul 20223:56 pmRNSHolding(s) in Company
30th Jun 20227:20 amRNSNotice of Investor Presentation
30th Jun 20227:00 amRNSFinal Results
28th Jun 20227:00 amRNSNotice of Preliminary Results
7th Jun 20227:00 amRNSDirectorate Change
29th Apr 20227:00 amRNSFull Year Trading Update
9th Mar 20224:41 pmRNSSecond Price Monitoring Extn
9th Mar 20224:36 pmRNSPrice Monitoring Extension
21st Jan 20224:41 pmRNSSecond Price Monitoring Extn
21st Jan 20224:35 pmRNSPrice Monitoring Extension
18th Jan 20227:00 amRNSDirector/PDMR Shareholding
30th Dec 20214:42 pmRNSSecond Price Monitoring Extn
30th Dec 20214:36 pmRNSPrice Monitoring Extension
7th Dec 20214:41 pmRNSSecond Price Monitoring Extn
7th Dec 20214:36 pmRNSPrice Monitoring Extension
1st Dec 20212:57 pmRNSHolding(s) in Company
25th Nov 20217:00 amRNSDirector/PDMR Shareholding
24th Nov 20217:00 amRNSDirector/PDMR Shareholding
24th Nov 20217:00 amRNSDirector/PDMR Shareholding
19th Nov 20217:00 amRNSHalf Year Results
5th Nov 20217:00 amRNSNotice of Interim Results & Investor Presentation
2nd Sep 20213:08 pmRNSResults of Annual General Meeting
2nd Sep 20217:00 amRNSAGM Trading Update
6th Aug 20217:00 amRNSDirector/PDMR Shareholding
26th Jul 20212:47 pmRNS2021 Annual Report & Notice of AGM
1st Jul 20217:00 amRNSDirector/PDMR Shareholding
1st Jul 20217:00 amRNSDirector/PDMR Shareholding
30th Jun 20219:29 amRNSNotice of Investor Presentation
30th Jun 20217:00 amRNSPreliminary Results for the year ended 31 March 21

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.